Mechanism of action of streptonigrin in leukemic cells.
D000255:Adenosine Triphosphate / Q000378:metabolism*; D000903:Antibiotics, Antineoplastic / Q000494:pharmacology*; D002247:Carbon Isotopes; D004247:DNA / Q000378:metabolism*; D006801:Humans; D007945:Leukemia, Lymphoid / Q000378:metabolism*; D008099:Liver / Q000378:metabolism; D008214:Lymphocytes / Q000187:drug effects* / Q000378:metabolism*; D008937:Mitomycins / Q000494:pharmacology; D009243:NAD / Q000378:metabolism; D009963:Orotic Acid / Q000378:metabolism; D010084:Oxidation-Reduction; D010101:Oxygen Consumption / Q000187:drug effects*; D010455:Peptides / Q000378:metabolism; D010545:Peroxides / Q000096:biosynthesis; D010649:Phenylalanine / Q000378:metabolism; D011506:Proteins / Q000378:metabolism*; D011691:Puromycin / Q000494:pharmacology; D012313:RNA / Q000378:metabolism*; D012270:Ribosomes / Q000378:metabolism*; D013308:Streptonigrin / Q000494:pharmacology; D013936:Thymidine / Q000378:metabolism; D014316:Tritium
D000903:Antibiotics, Antineoplastic; D002247:Carbon Isotopes; D008937:Mitomycins; D010455:Peptides; D010545:Peroxides; D011506:Proteins; D009243:NAD; D014316:Tritium; D013308:Streptonigrin; D010649:Phenylalanine; D011691:Puromycin; D009963:Orotic Acid; D012313:RNA; D000255:Adenosine Triphosphate; D004247:DNA; D013936:Thymidine